TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stressCOMMUNICATIONS BIOLOGYIF5.12022-06-093OAAI
Schlafen 11 (SLFN11) as a predictive biomarker of the response to TAS1553, a novel small molecule ribonucleotide reductase subunit interaction inhibitorMOLECULAR CANCER THERAPEUTICSIF5.52021-12-010PRE
TAS1553, a novel class of RNR inhibitor, demonstrates synergistic antitumor efficacy in combination with nucleoside analoguesMOLECULAR CANCER THERAPEUTICSIF5.52019-12-010PRE
TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based ChemotherapyMOLECULAR CANCER THERAPEUTICSIF5.52018-07-3126OAAI
In Vitro Characterization of a Novel dUTPase Inhibitor, TAS-114, as a Fluoropyrimidine EnhancerEUROPEAN JOURNAL OF CANCERIF7.12012-11-011PREAI
1,2,3-Triazole-Containing Uracil Derivatives with Excellent Pharmacokinetics as a Novel Class of Potent Human Deoxyuridine Triphosphatase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-07-0366PREAI
Discovery of Highly Potent Human Deoxyuridine Triphosphatase Inhibitors Based on the Conformation Restriction StrategyJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-05-3032PREAI
Synthesis and Discovery of N-Carbonylpyrrolidine- or N-Sulfonylpyrrolidine-Containing Uracil Derivatives as Potent Human Deoxyuridine Triphosphatase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-03-2620PREAI
Discovery of a Novel Class of Potent Human Deoxyuridine Triphosphatase Inhibitors Remarkably Enhancing the Antitumor Activity of Thymidylate Synthase InhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-03-2645PREAI
Electrooxidative glycosylation through C-S bond cleavage of 1-arylthio-2,3-dideoxyglycosides.: Synthesis of 2′,3′-dideoxynucleosidesORGANIC LETTERSIF52005-09-1634PREAI
Electrooxidation of alcohols in an N-oxyl-immobilized poly(ethylene-co-acrylic acid)/water disperse systemBULLETIN OF THE CHEMICAL SOCIETY OF JAPANIF3.82005-08-3020PREAI